Pulmonary Vascular Disease
Questions discussed in this category
The patient takes frequent flights for their job, with no prior history of VTE, and has already been taking measures for prevention including frequent...
Is there a difference in monitoring frequency for legacy drugs like bosentan vs newer agents (macitentan, ambrisentan)?
If there are a low-risk patients who can be monitored, how would you do so?
If unprovoked, would you consider stopping anticoagulation?
21775189041688214183134778198
Papers discussed in this category
AJR Am J Roentgenol,
Cochrane Database Syst Rev, 2021 Mar 26
Blood Adv,
CMAJ,
N Engl J Med, 2021 Jan 13
Journal of general internal medicine, 2007-01
Blood advances, 2018-11-27
Blood advances, 2023 Nov 28